Filana Therapeutics (FLNA) Cash from Operations (2010 - 2026)
Filana Therapeutics (FLNA) posted quarterly Cash from Operations of 3833000.0 for Q2 2026, up 22.78% year-over-year from 3121741.1 in Q2 2025, and up 56.93% quarter-over-quarter from 8900000.0 in Q1 2026.
Filana Therapeutics (FLNA) Cash from Operations (2010 - 2026) Analysis & Trends
Filana Therapeutics' Cash from Operations history runs 17 years deep, the most recent figure standing at 3833000.0 for Q2 2026.
- In Q2 2026, Cash from Operations rose 22.78% year-over-year to 3833000.0; the TTM figure through Jun 2026 stood at 28733000.0 (up 70.02% YoY), while the FY2025 annual figure was 32300000.0, up 72.38% from the prior year.
- Cash from Operations for Q2 2026 stood at 3833000.0, up from 8900000.0 in the prior quarter.
- The five-year high for Cash from Operations was 3833000.0 in Q2 2026, with the low at 61229000.0 in Q4 2024.
- The 5-year median for Cash from Operations is 18286500.0 (2024), against an average of 17861166.67.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations plunged 920.38% in 2022, then jumped 84.0% in 2025.
- Filana Therapeutics' Cash from Operations stood at 21320000.0 in 2022, then decreased by 4.67% to 22316000.0 in 2023, then sank by 174.37% to 61229000.0 in 2024, then surged by 84.0% to 9796000.0 in 2025, then surged by 60.87% to 3833000.0 in 2026.
- Business Quant data shows FLNA's Cash from Operations at 3833000.0 in Q2 2026, 8900000.0 in Q1 2026, and 9796000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 326.72 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -88.83 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 728.46 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.27 Mn |
| 10 | Filana Therapeutics | 45.29 Mn | 45.29 Mn | - | -3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.83 Mn |
| Jun 30, 2026 | -3.83 Mn |
| Mar 31, 2026 | -8.90 Mn |
| Mar 31, 2026 | -8.90 Mn |
| Dec 31, 2025 | -9.80 Mn |
| Dec 31, 2025 | -9.80 Mn |
| Sep 30, 2025 | -6.20 Mn |
| Sep 30, 2025 | -6.20 Mn |
| Jun 30, 2025 | -4.96 Mn |
| Jun 30, 2025 | -4.96 Mn |
| Mar 31, 2025 | -11.34 Mn |
| Mar 31, 2025 | -11.34 Mn |
| Dec 31, 2024 | -61.23 Mn |
| Dec 31, 2024 | -61.23 Mn |
| Sep 30, 2024 | -18.30 Mn |
| Sep 30, 2024 | -18.30 Mn |
| Jun 30, 2024 | -18.27 Mn |
| Jun 30, 2024 | -18.27 Mn |
| Mar 31, 2024 | -19.13 Mn |
| Mar 31, 2024 | -19.13 Mn |